| T-BSDB-H300 |
Recombinant Human Anti-CD64 x Anti-HER2 Bispecific Antibody (Tandem Diabody) |
Human |
|
CD64 |
HER2 |
Inquiry |
| T-BSDB-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Tandem Diabody) |
Human |
|
CD64 |
HER2 |
Inquiry |
| SCIGG-H302 |
Recombinant Human Anti-CD64 x Human Anti-HER2 Bispecific Antibody (scIgG) |
Human |
Single chain IgGs |
CD64 |
HER2 |
Inquiry |
| FABVC-394 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Fab-VHH-Fc) |
Human |
Fab-Fc Fusion Proteins |
CD64 |
HER2 |
Inquiry |
| BSSG-394 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (VHH-IgG) |
Human |
Appended IgGs |
CD64 |
HER2 |
Inquiry |
| HCAB-039 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (VHH-Fc-VHH) |
Human |
Constant Domain-extended Bispecific Fragments |
CD64 |
HER2 |
Inquiry |
| BIBD-394 |
Recombinant Anti-CD64 x Anti-HER2 VHH BispecificAntibody (Bibody) |
Human |
Bibody |
CD64 |
HER2 |
Inquiry |
| IGVHH-039 |
Recombinant Anti-CD64 x Anti-HER2 VHH BispecificAntibody (IgG-VHH) |
Human |
Appended IgGs |
CD64 |
HER2 |
Inquiry |
| BIVHH-039 |
Recombinant Anti-CD64 VHH x Anti-HER2 VHH BispecificAntibody (Bi-sdAb) |
Human |
Bi-sdAb |
CD64 |
HER2 |
Inquiry |
| SCIGG-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (scIgG) |
Human |
Single chain IgGs |
CD64 |
HER2 |
Inquiry |
| FVTIG-H302 |
Recombinant Human Anti-CD64 x Human Anti-HER2 Bispecific Antibody (scFv4-Ig) |
Human |
Appended IgGs |
CD64 |
HER2 |
Inquiry |
| FVTIG-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (scFv4-Ig) |
Human |
Appended IgGs |
CD64 |
HER2 |
Inquiry |
| BSSG-H302 |
Recombinant Human Anti-CD64 x Human Anti-HER2 Bispecific Antibody (scFv-IgG) |
Human |
Appended IgGs |
CD64 |
HER2 |
Inquiry |
| BSSG-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (scFv-IgG) |
Human |
Appended IgGs |
CD64 |
HER2 |
Inquiry |
| IGLFV-H302 |
Recombinant Human Anti-CD64 x Human Anti-HER2 Bispecific Antibody (IgG(L)-scFv) |
Human |
Appended IgGs |
CD64 |
HER2 |
Inquiry |
| IGLFV-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (IgG(L)-scFv) |
Human |
Appended IgGs |
CD64 |
HER2 |
Inquiry |
| BSGV-H302 |
Recombinant Human Anti-CD64 x Human Anti-HER2 Bispecific Antibody (IgG-Fv) |
Human |
IgG-Fv |
CD64 |
HER2 |
Inquiry |
| BSGV-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (IgG-Fv) |
Human |
IgG-Fv |
CD64 |
HER2 |
Inquiry |
| BSDG-H302 |
Recombinant Human Anti-CD64 x Human Anti-HER2 Bispecific Antibody (Fv-IgG) |
Human |
Appended IgGs |
CD64 |
HER2 |
Inquiry |
| BSDG-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Fv-IgG) |
Human |
Appended IgGs |
CD64 |
HER2 |
Inquiry |
| BABFV-H302 |
Recombinant Human Anti-CD64 x Human Anti-HER2 Bispecific Antibody (F(ab')2-scFv2) |
Human |
Fab-Fc Fusion Proteins |
CD64 |
HER2 |
Inquiry |
| BABFV-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (F(ab')2-scFv2) |
Human |
Fab-Fc Fusion Proteins |
CD64 |
HER2 |
Inquiry |
| FABVC-H302 |
Recombinant Human Anti-CD64 x Human Anti-HER2 Bispecific Antibody (Fab-scFv-Fc) |
Human |
Fab-Fc Fusion Proteins |
CD64 |
HER2 |
Inquiry |
| FABVC-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Fab-scFv-Fc) |
Human |
Fab-Fc Fusion Proteins |
CD64 |
HER2 |
Inquiry |
| SCDBC-H302 |
Recombinant Human Anti-CD64 x Human Anti-HER2 Bispecific Antibody (scDiabody-CH3) |
Human |
Constant Domain-extended Bispecific Fragments |
CD64 |
HER2 |
Inquiry |
| SCDBC-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (scDiabody-CH3) |
Human |
Constant Domain-extended Bispecific Fragments |
CD64 |
HER2 |
Inquiry |
| BSDBC-H302 |
Recombinant Human Anti-CD64 x Human Anti-HER2 Bispecific Antibody (Diabody-CH3) |
Human |
Constant Domain-extended Bispecific Fragments |
CD64 |
HER2 |
Inquiry |
| BSDBC-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Diabody-CH3) |
Human |
Constant Domain-extended Bispecific Fragments |
CD64 |
HER2 |
Inquiry |
| SCDBF-H302 |
Recombinant Human Anti-CD64 x Human Anti-HER2 Bispecific Antibody (scDiabody-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD64 |
HER2 |
Inquiry |
| SCDBF-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (scDiabody-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD64 |
HER2 |
Inquiry |
| BSFVF-H302 |
Recombinant Human Anti-CD64 x Human Anti-HER2 Bispecific Antibody (Tandem scFv-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD64 |
HER2 |
Inquiry |
| BSFVF-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Tandem scFv-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD64 |
HER2 |
Inquiry |
| BSDBF-H302 |
Recombinant Human Anti-CD64 x Human Anti-HER2 Bispecific Antibody (Diabody-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD64 |
HER2 |
Inquiry |
| BSDBF-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Diabody-Fc) |
Human |
Constant Domain-extended Bispecific Fragments |
CD64 |
HER2 |
Inquiry |
| BSTF-H302 |
Recombinant Human Anti-CD64 x Human Anti-HER2 Bispecific Antibody (scFv-Fc-scFv) |
Human |
scFv-based Bispecific Fragments |
CD64 |
HER2 |
Inquiry |
| BSTF-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (scFv-Fc-scFv) |
Human |
scFv-based Bispecific Fragments |
CD64 |
HER2 |
Inquiry |
| BSCFV-H302 |
Recombinant Human Anti-CD64 x Human Anti-HER2 Bispecific Antibody (scFv-Fc) |
Human |
scFv-based Bispecific Fragments |
CD64 |
HER2 |
Inquiry |
| BSCFV-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (scFv-Fc) |
Human |
scFv-based Bispecific Fragments |
CD64 |
HER2 |
Inquiry |
| MNAB-H302 |
Recombinant Human Anti-CD64 x Human Anti-HER2 Bispecific Antibody (Miniantibody) |
Human |
scFv-based Bispecific Fragments |
CD64 |
HER2 |
Inquiry |
| MNAB-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Miniantibody) |
Human |
scFv-based Bispecific Fragments |
CD64 |
HER2 |
Inquiry |
| BSFC-H302 |
Recombinant Human Anti-CD64 x Human Anti-HER2 Bispecific Antibody (scFv-CH3) |
Human |
scFv-based Bispecific Fragments |
CD64 |
HER2 |
Inquiry |
| BSFC-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (scFv-CH3) |
Human |
scFv-based Bispecific Fragments |
CD64 |
HER2 |
Inquiry |
| BSCC-H302 |
Recombinant Human Anti-CD64 x Human Anti-HER2 Bispecific Antibody (scFv-CH1/CL) |
Human |
scFv-based Bispecific Fragments |
CD64 |
HER2 |
Inquiry |
| BSCC-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (scFv-CH1/CL) |
Human |
scFv-based Bispecific Fragments |
CD64 |
HER2 |
Inquiry |
| BIBD-H302 |
Recombinant Human Anti-CD64 x Human Anti-HER2 Bispecific Antibody (Bibody) |
Human |
Bibody |
CD64 |
HER2 |
Inquiry |
| BIBD-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Bibody) |
Human |
Bibody |
CD64 |
HER2 |
Inquiry |
| FABFV-H302 |
Recombinant Human Anti-CD64 x Human Anti-HER2 Bispecific Antibody (Fab-Fv) |
Human |
Fab-Fv |
CD64 |
HER2 |
Inquiry |
| FABFV-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Fab-Fv) |
Human |
Fab-Fv |
CD64 |
HER2 |
Inquiry |
| MiniB-H302 |
Recombinant Human Anti-CD64 x Human Anti-HER2 Bispecific Antibody (Minibody) |
Human |
Minibody |
CD64 |
HER2 |
Inquiry |
| MiniB-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Minibody) |
Human |
Minibody |
CD64 |
HER2 |
Inquiry |
| SCTB-H191 |
Recombinant Human Anti-HER2 x Human Anti-CD64 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
CD64 |
HER2 |
Inquiry |
| SCDB-H300 |
Recombinant Human Anti-CD64 x Anti-HER2 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD64 |
HER2 |
Inquiry |
| FABIG-H300 |
Recombinant Human Anti-CD64 x Anti-HER2 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD64 |
HER2 |
Inquiry |
| TRIB-H302 |
Recombinant Human Anti-CD64 x Anti-HER2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD64 |
HER2 |
Inquiry |
| BSIG-H300 |
Human Anti-CD64 x Anti-HER2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD64 |
HER2 |
Inquiry |
| CROSSAB-H300 |
Recombinant Human Anti-CD64 x Anti-HER2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD64 |
HER2 |
Inquiry |
| IGFV-H300 |
Recombinant Human Anti-CD64 x Anti-HER2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD64 |
HER2 |
Inquiry |
| BSDB-H300 |
Recombinant Human Anti-CD64 x Anti-HER2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD64 |
HER2 |
Inquiry |
| BSFAB-H300 |
Recombinant Human Anti-CD64 x Anti-HER2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD64 |
HER2 |
Inquiry |
| BSFV-H300 |
Recombinant Human Anti-CD64 x Anti-HER2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD64 |
HER2 |
Inquiry |
| SCTB-096 |
Recombinant Anti-HER2 x Anti-CD64 Bispecific Antibody (Single-chain Triplebody) |
Human |
Single-chain Triplebody |
CD64 |
HER2 |
Inquiry |
| SCDB-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Single-chain Diabody) |
Human |
Single-chain Diabody |
CD64 |
HER2 |
Inquiry |
| FABIG-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Fab-IgG) |
Human |
Fab-IgG |
CD64 |
HER2 |
Inquiry |
| TRIB-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Triple Body) |
Human |
Triple Body |
CD64 |
HER2 |
Inquiry |
| BSIG-128 |
Anti-CD64 x Anti-HER2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CD64 |
HER2 |
Inquiry |
| CROSSAB-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD64 |
HER2 |
Inquiry |
| IGFV-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD64 |
HER2 |
Inquiry |
| BSDB-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD64 |
HER2 |
Inquiry |
| BSFAB-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD64 |
HER2 |
Inquiry |
| BSFV-128 |
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD64 |
HER2 |
Inquiry |
| BSIG-025 |
Anti-CA125 x Anti-HER2 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
CA125 |
HER2 |
Inquiry |
| BSIG-023 |
Anti-C. albicans x Anti-CD64 Bispecific Antibody (IgG-IgG) |
Human |
IgG-IgG |
C. albicans |
CD64 |
Inquiry |
| BSIG-001 |
Anti-B Cell Lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (IgG-IgG) |
Mouse |
IgG-IgG |
B Cell Lymphoma BCL1 Idiotype |
CD64 |
Inquiry |
| CROSSAB-167 |
Recombinant Anti-HER2 x Anti-HER3 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
HER2 |
HER3 |
Inquiry |
| CROSSAB-166 |
Recombinant Anti-HER2 x Anti-MET Bispecific Antibody (CrossMab) |
Human |
CrossMab |
HER2 |
MET |
Inquiry |
| CROSSAB-155 |
Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
EGFR |
HER2 |
Inquiry |
| CROSSAB-147 |
Recombinant Anti-DENV x Anti-CD64 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
DENV |
CD64 |
Inquiry |
| CROSSAB-129 |
Recombinant Anti-CD64 x Anti-Malaria Antigen Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD64 |
Malaria Antigen |
Inquiry |
| CROSSAB-127 |
Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD64 |
HIV-1 gp41 |
Inquiry |
| CROSSAB-126 |
Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD64 |
GD2 |
Inquiry |
| CROSSAB-125 |
Recombinant Anti-CD64 x Anti-EGFR Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD64 |
EGFR |
Inquiry |
| CROSSAB-117 |
Recombinant Anti-CD37 x Anti-CD64 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD37 |
CD64 |
Inquiry |
| CROSSAB-115 |
Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD33 |
CD64 |
Inquiry |
| CROSSAB-110 |
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD30 |
CD64 |
Inquiry |
| CROSSAB-090 |
Recombinant Anti-CD3 x Anti-HER2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD3 |
HER2 |
Inquiry |
| CROSSAB-044 |
Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD19 |
CD64 |
Inquiry |
| CROSSAB-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD16 |
HER2 |
Inquiry |
| CROSSAB-032 |
Recombinant Anti-CD15 x Anti-CD64 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CD15 |
CD64 |
Inquiry |
| CROSSAB-025 |
Recombinant Anti-CA125 x Anti-HER2 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
CA125 |
HER2 |
Inquiry |
| CROSSAB-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (CrossMab) |
Human |
CrossMab |
C. albicans |
CD64 |
Inquiry |
| CROSSAB-001 |
Recombinant Anti-B Cell Lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (CrossMab) |
Mouse |
CrossMab |
B Cell Lymphoma BCL1 Idiotype |
CD64 |
Inquiry |
| IGFV-168 |
Recombinant Anti-HER2 x Anti-VEGF Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
HER2 |
VEGF |
Inquiry |
| IGFV-167 |
Recombinant Anti-HER2 x Anti-HER3 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
HER2 |
HER3 |
Inquiry |
| IGFV-166 |
Recombinant Anti-HER2 x Anti-MET Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
HER2 |
MET |
Inquiry |
| IGFV-155 |
Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
EGFR |
HER2 |
Inquiry |
| IGFV-147 |
Recombinant Anti-DENV x Anti-CD64 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
DENV |
CD64 |
Inquiry |
| IGFV-129 |
Recombinant Anti-CD64 x Anti-Malaria Antigen Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD64 |
Malaria Antigen |
Inquiry |
| IGFV-127 |
Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD64 |
HIV-1 gp41 |
Inquiry |
| IGFV-126 |
Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD64 |
GD2 |
Inquiry |
| IGFV-125 |
Recombinant Anti-CD64 x Anti-EGFR Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD64 |
EGFR |
Inquiry |
| IGFV-117 |
Recombinant Anti-CD37 x Anti-CD64 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD37 |
CD64 |
Inquiry |
| IGFV-115 |
Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD33 |
CD64 |
Inquiry |
| IGFV-110 |
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD30 |
CD64 |
Inquiry |
| IGFV-090 |
Recombinant Anti-CD3 x Anti-HER2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD3 |
HER2 |
Inquiry |
| IGFV-044 |
Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD19 |
CD64 |
Inquiry |
| IGFV-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD16 |
HER2 |
Inquiry |
| IGFV-032 |
Recombinant Anti-CD15 x Anti-CD64 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
CD15 |
CD64 |
Inquiry |
| IGFV-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (IgG-scFv) |
Human |
IgG-scFv |
C. albicans |
CD64 |
Inquiry |
| IGFV-001 |
Recombinant Anti-B Cell Lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (IgG-scFv) |
Mouse |
IgG-scFv |
B Cell Lymphoma BCL1 Idiotype |
CD64 |
Inquiry |
| BSDB-168 |
Recombinant Anti-HER2 x Anti-VEGF Bispecific Antibody (Diabody) |
Human |
Diabody |
HER2 |
VEGF |
Inquiry |
| BSDB-167 |
Recombinant Anti-HER2 x Anti-HER3 Bispecific Antibody (Diabody) |
Human |
Diabody |
HER2 |
HER3 |
Inquiry |
| BSDB-166 |
Recombinant Anti-HER2 x Anti-MET Bispecific Antibody (Diabody) |
Human |
Diabody |
HER2 |
MET |
Inquiry |
| BSDB-155 |
Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (Diabody) |
Human |
Diabody |
EGFR |
HER2 |
Inquiry |
| BSDB-147 |
Recombinant Anti-DENV x Anti-CD64 Bispecific Antibody (Diabody) |
Human |
Diabody |
DENV |
CD64 |
Inquiry |
| BSDB-129 |
Recombinant Anti-CD64 x Anti-Malaria Antigen Bispecific Antibody (Diabody) |
Human |
Diabody |
CD64 |
Malaria Antigen |
Inquiry |
| BSDB-127 |
Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD64 |
HIV-1 gp41 |
Inquiry |
| BSDB-126 |
Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD64 |
GD2 |
Inquiry |
| BSDB-125 |
Recombinant Anti-CD64 x Anti-EGFR Bispecific Antibody (Diabody) |
Human |
Diabody |
CD64 |
EGFR |
Inquiry |
| BSDB-117 |
Recombinant Anti-CD37 x Anti-CD64 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD37 |
CD64 |
Inquiry |
| BSDB-115 |
Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD33 |
CD64 |
Inquiry |
| BSDB-110 |
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD30 |
CD64 |
Inquiry |
| BSDB-090 |
Recombinant Anti-CD3 x Anti-HER2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD3 |
HER2 |
Inquiry |
| BSDB-044 |
Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD19 |
CD64 |
Inquiry |
| BSDB-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD16 |
HER2 |
Inquiry |
| BSDB-032 |
Recombinant Anti-CD15 x Anti-CD64 Bispecific Antibody (Diabody) |
Human |
Diabody |
CD15 |
CD64 |
Inquiry |
| BSDB-025 |
Recombinant Anti-CA125 x Anti-HER2 Bispecific Antibody (Diabody) |
Human |
Diabody |
CA125 |
HER2 |
Inquiry |
| BSDB-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Diabody) |
Human |
Diabody |
C. albicans |
CD64 |
Inquiry |
| BSDB-001 |
Recombinant Anti-B Cell Lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (Diabody) |
Mouse |
Diabody |
B Cell Lymphoma BCL1 Idiotype |
CD64 |
Inquiry |
| BSFAB-168 |
Recombinant Anti-HER2 x Anti-VEGF Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
HER2 |
VEGF |
Inquiry |
| BSFAB-167 |
Recombinant Anti-HER2 x Anti-HER3 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
HER2 |
HER3 |
Inquiry |
| BSFAB-166 |
Recombinant Anti-HER2 x Anti-MET Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
HER2 |
MET |
Inquiry |
| BSFAB-155 |
Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
EGFR |
HER2 |
Inquiry |
| BSFAB-147 |
Recombinant Anti-DENV x Anti-CD64 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
DENV |
CD64 |
Inquiry |
| BSFAB-129 |
Recombinant Anti-CD64 x Anti-Malaria Antigen Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD64 |
Malaria Antigen |
Inquiry |
| BSFAB-127 |
Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD64 |
HIV-1 gp41 |
Inquiry |
| BSFAB-126 |
Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD64 |
GD2 |
Inquiry |
| BSFAB-125 |
Recombinant Anti-CD64 x Anti-EGFR Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD64 |
EGFR |
Inquiry |
| BSFAB-117 |
Recombinant Anti-CD37 x Anti-CD64 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD37 |
CD64 |
Inquiry |
| BSFAB-115 |
Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD33 |
CD64 |
Inquiry |
| BSFAB-110 |
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD30 |
CD64 |
Inquiry |
| BSFAB-090 |
Recombinant Anti-CD3 x Anti-HER2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD3 |
HER2 |
Inquiry |
| BSFAB-044 |
Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD19 |
CD64 |
Inquiry |
| BSFAB-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD16 |
HER2 |
Inquiry |
| BSFAB-032 |
Recombinant Anti-CD15 x Anti-CD64 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
CD15 |
CD64 |
Inquiry |
| BSFAB-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Tandem Fab) |
Human |
Tandem Fab |
C. albicans |
CD64 |
Inquiry |
| BSFAB-001 |
Recombinant Anti-B Cell Lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (Tandem Fab) |
Mouse |
Tandem Fab |
B Cell Lymphoma BCL1 Idiotype |
CD64 |
Inquiry |
| BSFV-168 |
Recombinant Anti-HER2 x Anti-VEGF Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
HER2 |
VEGF |
Inquiry |
| BSFV-167 |
Recombinant Anti-HER2 x Anti-HER3 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
HER2 |
HER3 |
Inquiry |
| BSFV-166 |
Recombinant Anti-HER2 x Anti-MET Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
HER2 |
MET |
Inquiry |
| BSFV-155 |
Recombinant Anti-EGFR x Anti-HER2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
EGFR |
HER2 |
Inquiry |
| BSFV-147 |
Recombinant Anti-DENV x Anti-CD64 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
DENV |
CD64 |
Inquiry |
| BSFV-129 |
Recombinant Anti-CD64 x Anti-Malaria Antigen Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD64 |
Malaria Antigen |
Inquiry |
| BSFV-127 |
Recombinant Anti-CD64 x Anti-HIV-1 gp41 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD64 |
HIV-1 gp41 |
Inquiry |
| BSFV-126 |
Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD64 |
GD2 |
Inquiry |
| BSFV-125 |
Recombinant Anti-CD64 x Anti-EGFR Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD64 |
EGFR |
Inquiry |
| BSFV-117 |
Recombinant Anti-CD37 x Anti-CD64 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD37 |
CD64 |
Inquiry |
| BSFV-115 |
Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD33 |
CD64 |
Inquiry |
| BSFV-110 |
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD30 |
CD64 |
Inquiry |
| BSFV-090 |
Recombinant Anti-CD3 x Anti-HER2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD3 |
HER2 |
Inquiry |
| BSFV-044 |
Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD19 |
CD64 |
Inquiry |
| BSFV-038 |
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD16 |
HER2 |
Inquiry |
| BSFV-032 |
Recombinant Anti-CD15 x Anti-CD64 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CD15 |
CD64 |
Inquiry |
| BSFV-025 |
Recombinant Anti-CA125 x Anti-HER2 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
CA125 |
HER2 |
Inquiry |
| BSFV-023 |
Recombinant Anti-C. albicans x Anti-CD64 Bispecific Antibody (Tandem scFv) |
Human |
Tandem scFv |
C. albicans |
CD64 |
Inquiry |
| BSFV-001 |
Recombinant Anti-B Cell Lymphoma BCL1 Idiotype x Anti-CD64 Bispecific Antibody (Tandem scFv) |
Mouse |
Tandem scFv |
B Cell Lymphoma BCL1 Idiotype |
CD64 |
Inquiry |
Fig.1 Structures of CD64 and HER2.1,2
